Could CRISPR be Used as Antimicrobials?

Bikard, D., Barrangou, R., (2017) Current Opinion in Microbiology, 37:155-160. https://www.ncbi.nlm.nih.gov/pubmed/28888103

Self-targeting bacteria with CRISPR usually proves fatal.  This observation could lead to a new type of antimicrobial where the CRISPR/Cas system is introduced to fight infection.  This review discusses how CRISPR/Cas could target bacterial infections, as well as how the system may be delivered to the infection site.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply